Monthly readings

January-March 2021

We invite you to consider for reading the following original papers, position papers, reviews and guidelines:

Research articles

Long, M.T., Zhang, X., Xu, H., Liu, C.T., Corey, K.E., Chung, R.T., Loomba, R. and Benjamin, E.J. (2021). Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study. Hepatology, 73: 548-559.


Wong F, Pappas SC, Curry MP, Reddy KR, Rubin RA, Porayko MK, Gonzalez SA, Mumtaz K, Lim N, Simonetto DA, Sharma P, Sanyal AJ, Mayo MJ, Frederick RT, Escalante S, Jamil K, for CONFIRM Study Investigators. Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome. N Engl J Med. 2021 Mar 4;384(9):818-828. doi: 10.1056/NEJMoa2008290. PMID: 33657294.


Costa D, Simbrunner B, Jachs M, Hartl L, Bauer D, Paternostro R, Schwabl P, Scheiner B, Stättermayer AF, Pinter M, Trauner M, Mandorfer M, Reiberger T. Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality. J Hepatol. 2020 Oct 16:S0168-8278(20)33684-9. doi: 10.1016/j.jhep.2020.10.004. Epub ahead of print. PMID: 33075344.


Choi J, Jo C, Lim YS. Tenofovir Versus Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma After Surgical Resection. Hepatology. 2021 Feb;73(2):661-673. doi: 10.1002/hep.31289. Epub 2020 Nov 2. PMID: 32324905


Sarah Blach, Loreta A. Kondili, Alessio Aghemo, Zongzhen Cai, Ellen Dugan, Chris Estes, Ivane Gamkrelidze, Siya Ma, Jean-Michel Pawlotsky, Devin Razavi-Shearer, Homie Razavi, Imam Waked, Stefan Zeuzem, Antonio Craxi. Impact of COVID-19 on global HCV elimination efforts. J Hepatol 2021; 74: 31–36;

Guidelines & Position papers

Cornberg M, Buti M, Eberhardt CS, Grossi PA, Shouval D. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients. J Hepatol. 2021 Feb 6;74(4):944–51. doi: 10.1016/j.jhep.2021.01.032. Epub ahead of print. PMID: 33563499; PMCID: PMC7867401.


Mathews SC, Sakulsaengprapha V. Digital Health Landscape in Gastroenterology and Hepatology. Clin Gastroenterol Hepatol. 2021 Mar;19(3):421-424.e2. doi: 10.1016/j.cgh.2020.11.001. Epub 2020 Nov 3. PMID: 33157314.


Wolf, E., Rich, N.E., Marrero, J.A., Parikh, N.D. and Singal, A.G. (2021). Use of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis: A Systematic Review and MetaAnalysis. Hepatology, 73: 713-725.


Anderson RT, Choi HSJ, Lenz O, Peters MG, Janssen HLA, Mishra P, Donaldson E, Westman G, Buchholz S, Miller V, Hansen BE. Association Between Seroclearance of Hepatitis B Surface Antigen and Long-term Clinical Outcomes of Patients With Chronic Hepatitis B Virus Infection: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2021 Mar;19(3):463-472. doi: 10.1016/j.cgh.2020.05.041. Epub 2020 May 27. PMID: 32473348.

Tilg H, Adolph TE, Moschen AR. Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade. Hepatology. 2021 Feb;73(2):833-842. doi: 10.1002/hep.31518. Epub 2021 Feb 6. PMID: 32780879; PMCID: PMC7898624.


Rimassa L, Personeni N, Czauderna C, Foerster F, Galle P. Systemic treatment of HCC in special populations. J Hepatol. 2020 Nov 26:S0168-8278(20)33813-7. doi: 10.1016/j.jhep.2020.11.026. Epub ahead of print. PMID: 33248171.